Latest Articles for Clinical Trials

GATher improves the prediction of drug targets using advanced graph technology.

Understanding the role of genetic testing in ALS and its implications.

AI models show promise in improving clinical trial patient eligibility screening.

Research aims to refine treatment lengths for tuberculosis.

New reference ranges enhance health testing in Kilifi, addressing local health challenges.

Using machine learning to improve clinical trial eligibility criteria and recruitment.

Exploring the use of surrogate markers for quicker treatment decisions in research.

A discussion on the importance of realistic assumptions in medical research estimands.

AI is transforming healthcare by enhancing patient care and reducing workloads.

A new malaria vaccine demonstrates effective protection for children in Burkina Faso.

A study on the quality of acupotomy trials shows room for improvement.

Exploring AI's role in speeding up vaccine creation during the pandemic.

A novel approach to identify patient-specific treatment effectiveness.

A new method enhances synthetic data generation for clinical trials while ensuring privacy.

Research reveals how oncologists' teamwork shapes patient access to clinical trials.

Examining the shift towards tailored prostate cancer screening based on genetic and family factors.

This study examines the effects of placebo on MSA patients in clinical trials.

Research shows promise for magnetic fields in improving bone health.

A look at the need for updated clinical trial databases.

Antibody therapies are changing treatment for infections and diseases.

An overview of molnupiravir's effectiveness and challenges in treating COVID-19.

The Fragility Index reveals the reliability of clinical trial results.

Study reveals how health history impacts Alzheimer’s cognitive decline.

A new classifier leverages AI to streamline oncology trial analysis.

A look at improving treatment effect analysis using tail-trimming techniques.

A new vaccine developed using RBD protein shows promise in fighting COVID-19.

FlowDock revolutionizes protein-ligand interactions for faster drug development.

Research uncovers promising gene targets for Parkinson's treatments.

Discover how AI and ontologies reshape clinical trial processing.

Study reveals how GBA1 variants impact Parkinson's symptoms and treatment responses.

Research unveils potential in neutrophils for CRC treatment strategies.

Exploring innovative strategies for Alzheimer's using existing drugs.

Synthetic data offers a secure way to analyze health information without privacy risks.